Cite
HARVARD Citation
Kuang, P. et al. (n.d.). Sustaining integrating imatinib and interferon-α into maintenance therapy improves survival of patients with Philadelphia positive acute lymphoblastic leukemia ineligible for allogeneic stem cell transplantation. Leukemia & lymphoma. 57 (10), pp. 2321-2329. [Online].